Xenetic Biosciences XBIO
NASDAQ XBIO
$2.26 -0.05 (-2.16%)
At close: Sep 29, 2026 · 4:00 PM EDT

Xenetic Biosciences (XBIO) Gross Margin (2011 - 2017)

Updated

Xenetic Biosciences (XBIO) recorded Gross Margin of -14.15% in Q3 2017.

Analysis

Xenetic Biosciences (XBIO) Gross Margin (2011 - 2017) Analysis & Trends

For FY2013, Xenetic Biosciences reported Gross Margin of 100.00%, up 15.27 percentage points from FY2012.

  • Across earlier years, Gross Margin came in at 84.73% in FY2012.
  • The Q3 2017 figure is the highest quarterly Gross Margin since Q3 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Xenetic Biosciences 5.46 Mn -20.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 -14.15%
May 31, 2013 74.81%
Feb 28, 2013 89.24%
Nov 30, 2012 63.79%
May 31, 2012 100.00%
Feb 29, 2012 76.03%
Nov 30, 2011 89.70%
API Access

Xenetic Biosciences Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=XBIO&period=max&api_key=YOUR_API_KEY